Generex Biotechnology Corporation

OTCPK:GNBT 株式レポート

時価総額:US$61.0k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Generex Biotechnology 過去の業績

過去 基準チェック /06

主要情報

-40.9%

収益成長率

8.5%

EPS成長率

Biotechs 業界の成長17.0%
収益成長率-65.8%
株主資本利益率n/a
ネット・マージン-5,378.7%
前回の決算情報30 Apr 2021

最近の業績更新

更新なし

Recent updates

収支内訳

Generex Biotechnology の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

OTCPK:GNBT 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Apr 211-37305
31 Jan 211-52284
31 Oct 202-35263
31 Jul 203-33182
30 Apr 202-26232
31 Jan 203-31252
31 Oct 195-36272
31 Jul 196-9252
30 Apr 19610152
31 Jan 19524101
31 Oct 1822741
31 Jul 1813621
30 Apr 181921
31 Jan 181-3721
31 Oct 170-4311
31 Jul 170-7010
30 Apr 170-6010
31 Jan 170-1700
31 Oct 160-100
31 Jul 160-310
30 Apr 160-221
31 Jan 160-421
31 Oct 150-431

質の高い収益: GNBT is currently unprofitable.

利益率の向上: GNBT is currently unprofitable.


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: Insufficient data to determine if GNBT's year-on-year earnings growth rate was positive over the past 5 years.

成長の加速: Unable to compare GNBT's earnings growth over the past year to its 5-year average as it is currently unprofitable

収益対業界: GNBT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (96.9%).


株主資本利益率

高いROE: GNBT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘